May 16 (Reuters) - HLS Therapeutics Inc HLS.V :
* HLS THERAPEUTICS ANNOUNCES Q1 2018 FINANCIAL RESULTS
* CASH AND CASH EQUIVALENTS $53.8 MILLION AT END OF Q1
* Q1 REVENUE $13.2 MILLION VERSUS $15.6 MILLION
* QTRLY NET LOSS $0.19 PER COMMON SHARE
May 16 (Reuters) - HLS Therapeutics Inc HLS.V :
* HLS THERAPEUTICS ANNOUNCES Q1 2018 FINANCIAL RESULTS
* CASH AND CASH EQUIVALENTS $53.8 MILLION AT END OF Q1
* Q1 REVENUE $13.2 MILLION VERSUS $15.6 MILLION
* QTRLY NET LOSS $0.19 PER COMMON SHARE